ESTEVE Expands Portfolio with Acquisition of Caprelsa® to Treat Medullary Thyroid Cancer Esteve has announced its acquisition of Caprelsa®, a drug for treating medullary thyroid cancer, from Sanofi, enhancing their specialized therapies.

ESTEVE Expands Portfolio with Acquisition of Caprelsa® to Treat Medullary Thyroid Cancer #Spain #Barcelona #ESTEVE #Caprelsa #Medullary_Thyroid_Cancer